283 related articles for article (PubMed ID: 2298368)
1. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.
Mueller C; Knoflach P; Zielinski CC
Gastroenterology; 1990 Mar; 98(3):639-46. PubMed ID: 2298368
[TBL] [Abstract][Full Text] [Related]
2. Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.
Schreiber S; Raedler A; Conn AR; Rombeau JL; MacDermott RP
Gut; 1992 Feb; 33(2):236-41. PubMed ID: 1541420
[TBL] [Abstract][Full Text] [Related]
3. Expanded CD4+CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease.
Roman LI; Manzano L; De La Hera A; Abreu L; Rossi I; Alvarez-Mon M
Gastroenterology; 1996 Apr; 110(4):1008-19. PubMed ID: 8612987
[TBL] [Abstract][Full Text] [Related]
4. Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease.
Matsuura T; West GA; Levine AD; Fiocchi C
Dig Liver Dis; 2000; 32(6):484-94. PubMed ID: 11057923
[TBL] [Abstract][Full Text] [Related]
5. Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis, and controls.
Kusugami K; Youngman KR; West GA; Fiocchi C
Gastroenterology; 1989 Jul; 97(1):1-9. PubMed ID: 2785943
[TBL] [Abstract][Full Text] [Related]
6. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor (VEGF) in Crohn's disease: increased production by peripheral blood mononuclear cells and decreased VEGF165 labeling of peripheral CD14+ monocytes.
Griga T; Werner S; Köller M; Tromm A; May B
Dig Dis Sci; 1999 Jun; 44(6):1196-201. PubMed ID: 10389696
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production in patients with inflammatory bowel disease.
Nakamura M; Saito H; Kasanuki J; Tamura Y; Yoshida S
Gut; 1992 Jul; 33(7):933-7. PubMed ID: 1644332
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 1 in Crohn's disease.
Satsangi J; Wolstencroft RA; Cason J; Ainley CC; Dumonde DC; Thompson RP
Clin Exp Immunol; 1987 Mar; 67(3):594-605. PubMed ID: 3496997
[TBL] [Abstract][Full Text] [Related]
10. Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.
Bross DA; Leichtner AM; Zurakowski D; Law T; Bousvaros A
J Pediatr Gastroenterol Nutr; 1996 Aug; 23(2):164-71. PubMed ID: 8856584
[TBL] [Abstract][Full Text] [Related]
11. Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease.
Suzuki Y; Saito H; Kasanuki J; Kishimoto T; Tamura Y; Yoshida S
Life Sci; 1990; 47(24):2193-7. PubMed ID: 2266787
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin 2 and CD8 and CD4 receptors in inflammatory bowel disease.
Matsuura T; West GA; Klein JS; Ferraris L; Fiocchi C
Gastroenterology; 1992 Jun; 102(6):2006-14. PubMed ID: 1587419
[TBL] [Abstract][Full Text] [Related]
13. T lymphocyte subsets in inflammatory bowel disease: peripheral blood.
Selby WS; Jewell DP
Gut; 1983 Feb; 24(2):99-105. PubMed ID: 6221976
[TBL] [Abstract][Full Text] [Related]
14. Immune system alterations in patients with inflammatory bowel disease during remission.
Sventoraityte J; Zvirbliene A; Kiudelis G; Zalinkevicius R; Zvirbliene A; Praskevicius A; Kupcinskas L; Tamosiūnas V
Medicina (Kaunas); 2008; 44(1):27-33. PubMed ID: 18277086
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn's disease (CD).
Giacomelli R; Passacantando A; Parzanese I; Vernia P; Klidara N; Cucinelli F; Lattanzio R; Santori E; Cipriani P; Caprilli R; Tonietti G
Clin Exp Immunol; 1998 Mar; 111(3):532-5. PubMed ID: 9528894
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood mononuclear-cell interleukin-2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease.
Ming RH; Atluru D; Spellman CW; Imir T; Goodwin JS; Strickland RG
J Clin Immunol; 1987 Jan; 7(1):59-63. PubMed ID: 3104392
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-2 receptor, interleukin-6 and interleukin-1 beta in patients with Crohn's disease and ulcerative colitis: preoperative levels and postoperative changes of serum concentrations.
Schürmann G; Betzler M; Post S; Herfarth C; Meuer S
Digestion; 1992; 51(1):51-9. PubMed ID: 1639222
[TBL] [Abstract][Full Text] [Related]
18. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
Danis VA; Heatley RV
Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease.
Fiocchi C; Hilfiker ML; Youngman KR; Doerder NC; Finke JH
Gastroenterology; 1984 Apr; 86(4):734-42. PubMed ID: 6607860
[TBL] [Abstract][Full Text] [Related]
20. [Mononuclear cell activation in Crohn's disease. Evaluation using serum assay of neopterin and interleukin-2 soluble receptors].
Duclos B; Reimund JM; Lang JM; Coumaros G; Chamouard P; Lehr L; Baumann R; Koehl C; Weill JP
Gastroenterol Clin Biol; 1990; 14(1):22-7. PubMed ID: 2311849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
